Vivanza Biosciences Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 515837,
    "name": "Vivanza Biosci.",
    "stock_name": "Vivanza Biosci.",
    "full_name": "Vivanza Biosciences Ltd",
    "name_url": "stocks-analysis/vivanza-biosci",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1.76",
    "chg": -0.04,
    "chgp": "-2.22%",
    "dir": -1,
    "prev_price": "1.80",
    "mcapval": "7.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530057,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 67,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE984E01035",
    "curr_date": "Sep 18, 03:30 PM",
    "curr_time": "07:26 AM",
    "last_traded_at": "Sep 18, 03:30 PM IST",
    "bse_nse_vol": "20.49 k",
    "exc_status": "Active",
    "traded_date": "Sep 18, 2026",
    "traded_date_str": "2026 09 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vivanza-biosci-515837-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vivanza Biosciences Downgraded to Sell Amid Technical Weakness and Long-Term Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivanza-biosciences-downgraded-to-sell-amid-technical-weakness-and-long-term-challenges-4160572",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/VivanzaBioscien_mojoScore_4160572.png",
        "date": "2026-08-19 08:18:08",
        "description": "Vivanza Biosciences Ltd has been downgraded from a Hold to a Sell rating following a comprehensive reassessment of its technical indicators, valuation metrics, financial trends, and overall quality. Despite recent positive quarterly sales growth, the company faces persistent operational losses, weak long-term fundamentals, and deteriorating technical signals that have collectively triggered this rating change."
      },
      {
        "title": "Vivanza Biosciences Ltd Upgraded to Hold on Technical and Financial Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivanza-biosciences-ltd-upgraded-to-hold-on-technical-and-financial-improvements-4152948",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/VivanzaBioscien_mojoScore_4152948.png",
        "date": "2026-08-14 08:13:55",
        "description": "Vivanza Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 13 Aug 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, and recent financial trends, despite lingering concerns over long-term fundamentals and debt servicing capacity."
      },
      {
        "title": "When is the next results date for Vivanza Biosciences Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-vivanza-biosciences-ltd-4127611",
        "imagepath": "",
        "date": "2026-07-29 23:17:04",
        "description": "The next results date for Vivanza Biosciences Ltd is scheduled for August 1, 2026...."
      },
      {
        "title": "Vivanza Biosciences Ltd Upgraded to Sell on Technical Improvements Despite Lingering Fundamental Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivanza-biosciences-ltd-upgraded-to-sell-on-technical-improvements-despite-lingering-fundamental-challenges-4091735",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VivanzaBioscien_mojoScore_4091735.png",
        "date": "2026-07-07 08:41:00",
        "description": "Vivanza Biosciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 6 July 2026, driven primarily by a shift in technical indicators. Despite this improvement, the company continues to face significant fundamental headwinds, including operating losses and weak long-term growth prospects, which keep the overall outlook cautious."
      },
      {
        "title": "Vivanza Biosciences Downgraded to Strong Sell Amid Technical and Fundamental Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivanza-biosciences-downgraded-to-strong-sell-amid-technical-and-fundamental-concerns-4080997",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VivanzaBioscien_mojoScore_4080997.png",
        "date": "2026-07-01 08:14:18",
        "description": "Vivanza Biosciences Ltd has been downgraded from a Sell to a Strong Sell rating as of 30 June 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results, the company’s micro-cap status, weak long-term growth, and unfavourable technical trends have prompted a reassessment of its investment appeal."
      }
    ],
    "total": 204,
    "sid": "515837",
    "stock_news_url": "https://www.marketsmojo.com/news/vivanza-biosciences-515837"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "12-Sep-2026",
      "details": "Revised Outcome of the 44th Annual General Meeting of the Vivanza Biosciences Limited",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "12-Sep-2026",
      "details": "Voting Result for the 44th Annual General Meeting of the Company",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "11-Sep-2026",
      "details": "Outcome of the 44th Annual General Meeting of the Members of the Vivanza Biosciences Limited.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Vivanza Biosciences Ltd has announced <strong>1:10</strong> stock split, ex-date: 24 Mar 23",
          "dt": "2023-03-24",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vivanza Biosciences Downgraded to Sell Amid Technical Weakness and Long-Term Challenges

2026-08-19 08:18:08

Vivanza Biosciences Ltd has been downgraded from a Hold to a Sell rating following a comprehensive reassessment of its technical indicators, valuation metrics, financial trends, and overall quality. Despite recent positive quarterly sales growth, the company faces persistent operational losses, weak long-term fundamentals, and deteriorating technical signals that have collectively triggered this rating change.

Read full news article

Vivanza Biosciences Ltd Upgraded to Hold on Technical and Financial Improvements

2026-08-14 08:13:55

Vivanza Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 13 Aug 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, and recent financial trends, despite lingering concerns over long-term fundamentals and debt servicing capacity.

Read full news article

When is the next results date for Vivanza Biosciences Ltd?

2026-07-29 23:17:04

The next results date for Vivanza Biosciences Ltd is scheduled for August 1, 2026....

Read full news article

Vivanza Biosciences Ltd Upgraded to Sell on Technical Improvements Despite Lingering Fundamental Challenges

2026-07-07 08:41:00

Vivanza Biosciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 6 July 2026, driven primarily by a shift in technical indicators. Despite this improvement, the company continues to face significant fundamental headwinds, including operating losses and weak long-term growth prospects, which keep the overall outlook cautious.

Read full news article

Vivanza Biosciences Downgraded to Strong Sell Amid Technical and Fundamental Concerns

2026-07-01 08:14:18

Vivanza Biosciences Ltd has been downgraded from a Sell to a Strong Sell rating as of 30 June 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results, the company’s micro-cap status, weak long-term growth, and unfavourable technical trends have prompted a reassessment of its investment appeal.

Read full news article

View All News